UBS analyst Brennan Hawken downgraded Ameriprise (AMP) to Neutral from Buy with a price target of $570, down from $580. The firm says its re-rating thesis has played out with the stock now trading in-line with peers on fiscal 2026 estimates. UBS also sees less loan growth upside for Ameriprise as the company’s lending offering has seen slower adoption of financial advisors.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMP: